APTO
Aptose Biosciences Inc
NASDAQ: APTO · HEALTHCARE · BIOTECHNOLOGY
$1.71
+0.00% today
Updated 2026-04-30
Market cap
$4.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-36.38
Dividend yield
—
52W range
$0 – $0
Volume
—
Aptose Biosciences Inc (APTO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4998.00 | $6.00 | $100023.00 | $43023.00 | $168807.00 | $124156.00 | $57800.00 | $42479.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | -99.9% | +1666950.0% | -57.0% | +292.4% | -26.5% | -53.4% | -26.5% | -100.0% | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $1000.00 | $2999.00 | $16000.00 | $2011.00 | $0.00 | $0.00 | $57800.00 | $42479.00 | $0.00 | $0.00 | $69109.00 | $114835.00 | $89092.00 | $83512.00 | $627251.00 | $646435.00 | $616527.00 | $507079.00 | $474545.00 | — |
| Gross profit | $3998.00 | $-2993.00 | $84023.00 | $41011.00 | $168807.00 | $124156.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-69109.00 | $-114835.00 | $-89092.00 | $-83512.00 | $-627251.00 | $-646435.00 | $-616527.00 | $-507079.00 | $-474545.00 | — |
| Gross margin | 80.0% | -49883.3% | 84.0% | 95.3% | 100.0% | 100.0% | 0.0% | 0.0% | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $11.47M | $9.30M | $3.16M | $6.13M | $3.76M | $2.40M | $2.35M | $1.93M | $3.18M | $3558.00 | $4.48M | $7.66M | $6.27M | $18.73M | $16.84M | $29.29M | $45.98M | $28.09M | $36.77M | $15.10M |
| SG&A | $5.03M | $5348.00 | $3.85M | $3.89M | $3.12M | $2.98M | $2.69M | $2.49M | $2.20M | $8203.00 | $7.05M | $6.13M | $5.50M | $10.37M | $10.02M | $26.48M | $19.46M | $14.51M | $15.59M | $11.15M |
| Operating income | $-17.42M | $-15.09M | $-7.63M | $-11.03M | $-6.57M | $-5.32M | $-5.10M | $-4.46M | $-5.42M | $-11762.00 | $-11.60M | $-13.89M | $-11.83M | $-29.11M | $-26.86M | $-55.77M | $-65.45M | $-42.60M | $-52.36M | $-26.26M |
| Operating margin | -348552.7% | -251439950.0% | -7624.0% | -25644.2% | -3894.6% | -4284.0% | -8821.9% | -10508.6% | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-15.55M | $-12.77M | $-6.53M | $-10.71M | $-5.71M | $-5.64M | $-5.02M | $-4.39M | $-5.34M | $-11.73M | $-10.43M | $-13.78M | $-11.74M | $-29.02M | $-26.26M | $-55.62M | $-65.30M | $-42.48M | $-52.27M | — |
| EBITDA margin | -311187.0% | -212816200.0% | -6533.0% | -24903.1% | -3382.6% | -4541.9% | -8692.9% | -10341.0% | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-17.42M | $-14.98M | $-7.63M | $-11.03M | $-5.88M | $-5.72M | $-5.08M | $-4.44M | $-5.38M | $-11.76M | $-10.50M | $-13.89M | $-11.83M | $-29.10M | $-26.87M | $-56.26M | $-65.45M | $-42.60M | $-52.36M | — |
| Interest expense | $0.00 | $1.05M | $1.05M | $1.03M | $648623.00 | $51179.00 | $14331.00 | $19408.00 | $5821.00 | $238692.00 | $30986.00 | $49103.00 | $68000.00 | $283000.00 | $574000.00 | $522000.00 | $92000.00 | $770000.00 | $0.00 | $207000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-17.58M | $-16.27M | $-9.02M | $-6.37M | $-8.09M | $5.08M | $-5.16M | $-4.48M | $-5.40M | $-11503.00 | $-10.54M | $-13.86M | $-11.66M | $-28.87M | $-26.28M | $-55.24M | $-65.35M | $-41.82M | $-51.21M | $-25.43M |
| Net income growth (YoY) | — | +7.5% | +44.6% | +29.3% | -26.8% | +162.8% | -201.5% | +13.2% | -20.6% | +99.8% | -91526.7% | -31.5% | +15.9% | -147.6% | +9.0% | -110.2% | -18.3% | +36.0% | -22.4% | +50.3% |
| Profit margin | -351773.2% | -271114333.3% | -9013.0% | -14815.7% | -4789.7% | 4091.9% | -8919.7% | -10540.6% | — | — | — | — | — | — | — | — | — | — | — | — |